Bots, editor, reviewer, Administrators
13,941
edits
Feed:Trial Acronyms: Difference between revisions
Jump to navigation
Jump to search
no edit summary
No edit summary |
No edit summary |
||
| Line 96: | Line 96: | ||
"ESSENCE" : "Efficacy and Safety of Subcutaneous Enoxaparin in Non–Q-Wave Coronary Events Study Group", | "ESSENCE" : "Efficacy and Safety of Subcutaneous Enoxaparin in Non–Q-Wave Coronary Events Study Group", | ||
"CRASH-2" : "Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage 2", | "CRASH-2" : "Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage 2", | ||
"APROCCHSS" : "Recombinant Human Activated Protein C and Low Dose of Hydrocortisone and Fludrocortisone in Adult Septic Shock", | |||
"3C" : "Cough Complication Cohort", | "3C" : "Cough Complication Cohort", | ||
"CHOICE" : "CHOICE is not an abbreviation per a communication with the research team", | "CHOICE" : "CHOICE is not an abbreviation per a communication with the research team", | ||